Enli Liu
Impact in
- Oncology top 0.2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Immunology 33
- Immune Cell Function and Interaction 31
- T-cell and B-cell Immunology 17
- Oncology 32
- CAR-T cell therapy research 29
- Co-authors
- Gianpietro Dotti (14 shared papers)Cliona M. Rooney (13 shared papers)Helen Elisabeth Heslop (12 shared papers)Barbara Savoldo (12 shared papers)Adrian P. Gee (11 shared papers)Hao Liu (8 shared papers)Malcolm K. Brenner (11 shared papers)Zhuyong Mei (8 shared papers)
- Journals
- Blood (23 papers)Nature Medicine (3 papers)Journal of Clinical Investigation (3 papers)Frontiers in Immunology (3 papers)Renewable Energy (2 papers)
- Partner nations
- United StatesCzechiaChina
In The Last Decade
Enli Liu
60 papers receiving 11.0k citations
Enli Liu's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 8.4k
- Immunology 4.9k
- Genetics 2.4k
- Hematology 903
- Genetics 827
Countries citing papers authored by Enli Liu
This map shows the geographic impact of Enli Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enli Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enli Liu more than expected).
Fields of papers citing papers by Enli Liu
This network shows the impact of papers produced by Enli Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enli Liu. The network helps show where Enli Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Enli Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors Hit paper breakdown → | 2020 | 1743 |
| 2 | Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy Hit paper breakdown → | 2011 | 1295 |
| 3 | Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma Hit paper breakdown → | 2008 | 1025 |
| 4 | Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma Hit paper breakdown → | 2011 | 981 |
| 5 | CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients Hit paper breakdown → | 2011 | 878 |
| 6 | Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma Hit paper breakdown → | 2015 | 867 |
| 7 | Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15 Hit paper breakdown → | 2014 | 641 |
| 8 | 2013 | 454 | |
| 9 | 2017 | 378 | |
| 10 | Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial Hit paper breakdown → | 2024 | 357 |
| 11 | 2016 | 249 | |
| 12 | 2020 | 246 | |
| 13 | 2021 | 214 | |
| 14 | 2017 | 179 | |
| 15 | 2006 | 176 | |
| 16 | 2014 | 168 | |
| 17 | 2022 | 145 | |
| 18 | 2003 | 133 | |
| 19 | 2021 | 126 | |
| 20 | 2023 | 87 |
About Enli Liu
Enli Liu is a scholar working on Immunology, Oncology, Genetics, Hematology and Rheumatology, having authored 60 papers that have together received 11.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (31 papers), CAR-T cell therapy research (29 papers), T-cell and B-cell Immunology (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Hematopoietic Stem Cell Transplantation (8 papers), Eosinophilic Disorders and Syndromes (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Pluripotent Stem Cells Research (3 papers). The work is most often cited by research in Oncology (8.4k citations), Immunology (4.9k citations), Genetics (2.4k citations), Hematology (903 citations) and Genetics (827 citations). Enli Liu has collaborated with scholars based in United States, Czechia and China. Frequent co-authors include Gianpietro Dotti, Cliona M. Rooney, Helen Elisabeth Heslop, Barbara Savoldo, Adrian P. Gee, Hao Liu, Malcolm K. Brenner, Zhuyong Mei, Bambi Grilley and Martin Pulé. Their work appears in journals such as Blood, Nature Medicine, Journal of Clinical Investigation, Frontiers in Immunology and Renewable Energy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.